Evidence map›Paper›PMID 42415568›Full record

ArticleArchiv der Pharmazie2026

Synthesis, Biological Evaluation, and Molecular Docking Studies of 2r,3t,4c-Configured C-Furanosidic LpxC Inhibitors.

André Behnk, Fabian Lüttchens, Frederick Wichter, Katharina Hoff, Elisa Venanzi, Stefan Wimmer, Christopher Vorreiter, Katharina Rox, Wolfgang Sippl, Ralph Holl

Abstract read
In one paragraph

Article in Archiv der Pharmazie, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

André BehnkInstitute of Organic Chemistry, Universität Hamburg, Hamburg, Germany.
Fabian LüttchensInstitute of Organic Chemistry, Universität Hamburg, Hamburg, Germany.
Frederick WichterInstitute of Organic Chemistry, Universität Hamburg, Hamburg, Germany.
Katharina HoffInstitute of Organic Chemistry, Universität Hamburg, Hamburg, Germany.
Elisa VenanziInstitute of Organic Chemistry, Universität Hamburg, Hamburg, Germany.
Stefan WimmerInstitute of Organic Chemistry, Universität Hamburg, Hamburg, Germany.
Christopher VorreiterInstitute of Pharmacy, Martin-Luther-University of Halle-Wittenberg, Halle (Saale), Germany.
Katharina RoxDepartment of Chemical Biology, Helmholtz Centre for Infection Research (HZI), Braunschweig, Germany.
Wolfgang SipplInstitute of Pharmacy, Martin-Luther-University of Halle-Wittenberg, Halle (Saale), Germany.ORCID https://orcid.org/0000-0002-5985-9261
Ralph HollInstitute of Organic Chemistry, Universität Hamburg, Hamburg, Germany.ORCID https://orcid.org/0000-0001-8511-3546

Funding

Deutsches Zentrum für Infektionsforschung TTU 09.717Deutsches Zentrum für Infektionsforschung TTU 09.719
6 · The paper itself

Abstract

In chiral pool syntheses starting from d-mannitol and d-galactose, a series of four 2r,3t,4c-configured C-furanosides was accessed. The synthesized stereoisomeric hydroxamic acids were tested for antibacterial activity as well as inhibitory potency toward the bacterial deacetylase LpxC, a promising target for antibiotics selectively targeting Gram-negative bacteria. The obtained biological data were compared with those of the previously synthesized 12 stereoisomers, and molecular docking as well as molecular dynamics studies were performed to rationalize the observed structure-activity relationships. Initial in vitro ADMET studies revealed excellent microsomal metabolic and plasma stability of the investigated C-furanosides.

Indexed as

AmidohydrolasesAnti-Bacterial AgentsEnzyme InhibitorsHydroxamic AcidsMolecular Docking SimulationGram-Negative BacteriaMicrobial Sensitivity TestsMolecular StructureStereoisomerismStructure-Activity RelationshipAmidohydrolasesAnti-Bacterial AgentsEnzyme InhibitorsHydroxamic AcidsUDP-3-O-acyl-N-acetylglucosamine deacetylaseantibacterialsC‐glycosidesin vitro ADMET studiesLpxC inhibitorsmolecular docking studies

Identifiers

PMID42415568
PMCPMC13342928

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.